(1 - 28 von 35
)
SynAct Pharma names Thomas Boesen as Chief Operating ...Cision News
news.cision.com
— SynAct Pharma AB (“SynAct”) today announced the appointment of Dr. Thomas Boesen as Chief Operating — SynAct Pharma AB (“SynAct”) today announced the appointment of Dr. Thomas Boesen as Chief Operating.
SynAct Pharma comments on ownership changes among ...Nasdaq
view.news.eu.nasdaq.com
— Owners of GoodWind includes Boesen Biotech ApS (COO Thomas Boesen), GL Capital AB (Torbjörn Bjerke, former CEO), Quantass ApS (Jeppe Øvlesen — Owners of GoodWind includes Boesen Biotech ApS (COO Thomas Boesen), GL Capital AB (Torbjörn Bjerke, former CEO), Quantass ApS (Jeppe Øvlesen ...
SynAct Pharma AB Names Thomas Boesen as Chief Operating ...Market Screener
www.marketscreener.com
› ...
SynAct Pharma names Thomas Boesen as Chief Operating Officer
ipohub.io
Dr. Boesen has more than 20 years’ experience in the biotech and pharma industry. With a PhD in bioorganic chemistry from Copenhagen University, studies at...
sortiert nach Relevanz / Datum